CHRISTINA YOHO: Open Payments
NPI 1164017372 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,511 in 104 payments from 22 companies in 2025. Trend: 2023 $1,469 · 2024 $1,843 · 2025 $2,511
Food & beverage: $2,477Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $634 |
| Novartis Pharmaceuticals Corporation | 14 | $320 |
| Amgen Inc. | 15 | $264 |
| CSL Behring | 9 | $243 |
| LEO Pharma Inc. | 7 | $174 |
| GENZYME CORPORATION | 6 | $153 |
| Blueprint Medicines Corporation | 4 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $80 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $63 |
Products named: TEZSPIRE, AIRSUPRA, DUPIXENT, AYVAKIT, ADBRY, FASENRA, Andembry, Rhapsido.
Industry payments across AL — which companies pay providers there.
